palmidrol has been researched along with Intestinal Diseases in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Paola, R | 1 |
| Impellizzeri, D | 1 |
| Torre, A | 1 |
| Mazzon, E | 1 |
| Cappellani, A | 1 |
| Faggio, C | 1 |
| Esposito, E | 1 |
| Trischitta, F | 1 |
| Cuzzocrea, S | 1 |
1 other study available for palmidrol and Intestinal Diseases
| Article | Year |
|---|---|
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; bcl-2-Associated X Protein; Disease Models | 2012 |